PACAP 38 inhibits adiponectin release

Neuroendocrinology Letters

Volumn 28, Issue 2, 2007, Pages 166-169

  Bik, Wojciech ^a   Wolinska Witort, Ewa ^a   Baranowska Bik, Agnieszka ^a   Martynska, Lidia ^a   Chmielowska, Magdalena ^a   Baranowska, Boguslawa ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Adiponectin; Inflammation; PACAP 38

Indexed keywords

ADIPONECTIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; LIPOPOLYSACCHARIDE; NEUROPEPTIDE; SODIUM CHLORIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOCRINE GLAND; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCOMPETENT CELL; INFLAMMATION; MALE; NONHUMAN; PROTEIN SECRETION; RAT;

EID: 34248378792     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sherwood NM, Krueckl SL, McRory JE: The origin and function of pituitary adenylate cyclase activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 2000; 21: 619-670.
2. Vaudry D, Gonzales BJ, Basille M, Yon L, Fournier A, Vaudry H: Pituitary adenylate cyclase activating polypeptide and its receptors: from structure to function. Pharmacol Rev 2000; 52: 269-324.
3. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank, SA, Wascheck JA: International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP). Pharmacol Rev 1998; 50: 265-270.
4. Reubi JC: In vitro evaluation of VIP/PACAP receptors in healthy and diseased human tissues. Clinical implications. Ann NY Acad Sci 2000; 921: 1-25.
5. Martinez C, Abad C, Delgado M, Arranz A, Juarranz MG, Rodriguez-Henche N, Brabet P, Laceta J, Gomariz R.P: Anti-inflammatory role in septic shock of pituitary adenylate cyclase activating polypeptide receptor. Proc Natl Acad Sci 2002; 99: 1053-1058.
6. Wei Y, Mojsov S: Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology. J Neuroendocrinol 1996; 8: 811-817.
7. 2 receptor in peripheral tissues of the mouse. Endocrinology 2004; 145: 1203-1210.
8. Akesson L, Ahren B, Edgren G, Degerman E: VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Endocrinology 2005; 146: 744-50.
9. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556.
10. Juge-Aubry CE, Henrichot E, Meier CA: Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 2005; 19: 547-566.
11. Berg AH, Scherer PE: Adipose tissue, inflammation and cardiovascular disease. Circ Res 2005; 96: 939-949.
12. Kadowaki T, Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-451.
13. Goldstein BJ, Scalia, R: Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004; 89: 2563-2568.
14. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME: Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 2004; 316: 924-929.
15. Saijo S, Nagata K, Nakano Y, Tobe T, Kobayashi Y: Inhibition by adiponectin of IL8 production by human macrophages upon coculturing with late apoptotic cells. Biochem Biophys Res Commun 2005; 334: 1180-1183.
16. Tsatsanis C, Zacharioudaki V, Androulidaki A, Dermitzaki E, Charalampopoulos I, Minas V, Gravanis A, Margioris AN: Adiponectin induced TNFα and IL6 in macrophages and promotes tolerance to itself and other proinflammatory stimuli. Biochem Biophys Res Commun 2005; 335: 1254-1263.
17. Delgado M, Martinez C, Pozo D, Calvo JR, Leceta J, Ganea D, Gomariz RP: Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNFα and IL6. J Immunol 1999; 162: 1200-1205.
18. Delgado M, Abad C, Martinez C, Juarranz MG, Leceta J, Ganea D, Gomariz RP: PACAP in immunity and inflammation. Ann NY Acad Sci 2003; 992: 141-157.
19. Bik W, Wolinska-Witort E, Pawlak J, Skwarlo-Sonta K, Chmielowska M, Martynska L, Baranowska-Bik A, Baranowska B: PACAP 38 as a modulator of immune and endocrine responses during LPS-induced acute inflammation in rats. J Neuroimmunol 2006; 177: 76-84
20. Ajuwon KM, Spurlock M.E: Adiponectin inhibits LPS-induced NF-κB activation and IL6 production and increases PPARγ2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 2005; 288: R1220-R1225.
21. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H: Adiponectin induces the anti-inflammatory cytokines IL10 and IL1-RA in human leukocytes. Biochem Biophys Res Commun 2004; 323: 630-635.
22. Ogunwobi OO, Beales IL: Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept 2006; 134: 105-113.
23. Sekiguchi Y, Kasai K, Hasegawa K, Suzuki Y, Shimoda, S: Glycogenolytic activity of pituitary adenylate cyclase-activating polypeptide (PACAP) in vivo and in vitro. Life Sci 1994; 55: 1219-1228.
24. Filipsson K, Pacini G, Scheurink AJ, Ahren B: PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice. Am J Physiol 1998; 274: E834-E842.
25. Akesson L, Ahren B, Manganiello VC, Holst LS, Edgren G, Degerman E: Dual effects of pituitary adenylate cyclase-activating polypeptide and isoproterenol on lipid metabolism and signaling in primary rat adipocytes. Endocrinology 2003; 144: 5293-5299.
26. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R: Adiponectin gene expression is inhibited by β-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 2001; 507: 142-146.
27. Delporte ML, Funahashi T, Takahashi M, Matsuzawa Y, Brichard SM: Pre- and post-translational negative effect of β-adrenergic agonist on adiponectin secretion: in vitro and in vivo studies. Biochem J 2002; 367: 677-685.